CMS Extends Oncology Quality Of Care Demo
This article was originally published in The Pink Sheet Daily
Executive Summary
The 2006 version of the demo project is expected to require that oncologists report clinical guideline adherence, rather than assess symptoms related to patient suffering.
You may also be interested in...
Avastin’s Off-Label Uptake May Be Slowed By ASP-Based Reimbursement
Medicare reimbursement changes make oncologists more likely to adhere to established treatment guidelines, Robert W. Baird analyst says.
Avastin’s Off-Label Uptake May Be Slowed By ASP-Based Reimbursement
Medicare reimbursement changes make oncologists more likely to adhere to established treatment guidelines, Robert W. Baird analyst says.
Oncology Reimbursement Changes Could Close Small Practices, Amgen Says
Amgen remains confident its oncology portfolio is on track to deliver growth despite changes in reimbursement in the market, Associate Director-Investor Relations Laura Biswas said